An injectable hydrogel-formulated inhibitor of prolyl-4-hydroxylase promotes T regulatory cell recruitment and enhances alveolar bone regeneration during resolution of experimental periodontitis.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
10 2020
Historique:
received: 17 05 2020
revised: 29 07 2020
accepted: 31 07 2020
pubmed: 20 8 2020
medline: 1 5 2021
entrez: 20 8 2020
Statut: ppublish

Résumé

The hypoxia-inducible factor 1α (HIF-1α) is critically involved in tissue regeneration. Hence, the pharmacological prevention of HIF-1α degradation by prolyl hydroxylase (PHD) under normoxic conditions is emerging as a promising option in regenerative medicine. Using a mouse model of ligature-induced periodontitis and resolution, we tested the ability of an injectable hydrogel-formulated PHD inhibitor, 1,4-dihydrophenonthrolin-4-one-3-carboxylic acid (1,4-DPCA/hydrogel), to promote regeneration of alveolar bone lost owing to experimental periodontitis. Mice injected subcutaneously with 1,4-DPCA/hydrogel at the onset of periodontitis resolution displayed significantly increased gingival HIF-1α protein levels and bone regeneration, as compared to mice treated with vehicle control. The 1,4-DPCA/hydrogel-induced increase in bone regeneration was associated with elevated expression of osteogenic genes, decreased expression of pro-inflammatory cytokine genes, and increased abundance of FOXP3

Identifiants

pubmed: 32812255
doi: 10.1096/fj.202001248R
pmc: PMC7722135
mid: NIHMS1630049
doi:

Substances chimiques

Cytokines 0
Enzyme Inhibitors 0
Forkhead Transcription Factors 0
Foxp3 protein, mouse 0
Hif1a protein, mouse 0
Hydrogels 0
Hypoxia-Inducible Factor 1, alpha Subunit 0
Hypoxia-Inducible Factor-Proline Dioxygenases EC 1.14.11.29

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13726-13740

Subventions

Organisme : NIDCR NIH HHS
ID : R37 DE026152
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE028561
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE021104
Pays : United States

Informations de copyright

© 2020 Federation of American Societies for Experimental Biology.

Références

J Dent Res. 2014 Nov;93(11):1045-53
pubmed: 25261053
J Periodontol. 2015 Feb;86(2 Suppl):S153-6
pubmed: 25317603
Stem Cells Int. 2018 Jul 30;2018:2495848
pubmed: 30154861
J Clin Periodontol. 2008 Sep;35(8 Suppl):106-16
pubmed: 18724845
Nat Rev Microbiol. 2018 Dec;16(12):745-759
pubmed: 30301974
Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):686-91
pubmed: 18184809
Cell Metab. 2018 Feb 6;27(2):281-298
pubmed: 29129785
J Dent Res. 2015 Jan;94(1):148-56
pubmed: 25389003
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):E2784-93
pubmed: 22988108
Adv Wound Care (New Rochelle). 2014 May 1;3(5):390-399
pubmed: 24804159
J Periodontol. 2015 Feb;86(2 Suppl):S134-52
pubmed: 25644297
J Periodontal Res. 2006 Dec;41(6):547-53
pubmed: 17076780
Periodontol 2000. 2015 Jun;68(1):182-216
pubmed: 25867987
J Cell Biochem. 2016 Feb;117(2):267-78
pubmed: 26206147
Int Dent J. 2013 Dec;63(6):306-11
pubmed: 24716244
J Periodontol. 2012 Oct;83(10):1279-87
pubmed: 22324467
Nat Med. 2011 Nov 20;17(12):1594-601
pubmed: 22101767
J Clin Periodontol. 2017 Mar;44 Suppl 18:S94-S105
pubmed: 28266116
J Biol Chem. 1996 Dec 13;271(50):32253-9
pubmed: 8943284
Nat Rev Dis Primers. 2017 Jun 22;3:17038
pubmed: 28805207
Trends Mol Med. 2018 Dec;24(12):1021-1035
pubmed: 30391126
Nat Immunol. 2019 Jan;20(1):40-49
pubmed: 30455459
J Immunol Methods. 2013 Aug 30;394(1-2):49-54
pubmed: 23672778
J Dent Res. 2013 Aug;92(8):709-15
pubmed: 23735585
Nat Med. 1998 Jan;4(1):72-7
pubmed: 9427609
Nat Commun. 2015 Sep 16;6:8272
pubmed: 26374165
BMJ. 2014 Apr 10;348:g2645
pubmed: 24721751
Nat Rev Immunol. 2011 Feb;11(2):119-30
pubmed: 21267013
Periodontol 2000. 2010 Jun;53:28-44
pubmed: 20403103
J Exp Med. 2003 Nov 3;198(9):1391-402
pubmed: 14597738
Sci Transl Med. 2015 Sep 30;7(307):307ra155
pubmed: 26424570
Chem Commun (Camb). 2005 Nov 21;(43):5438-40
pubmed: 16261239
Front Pharmacol. 2015 Sep 02;6:184
pubmed: 26388774
Cell. 2008 May 30;133(5):775-87
pubmed: 18510923
J Clin Invest. 2009 Oct;119(10):2898-913
pubmed: 19770521
Nat Immunol. 2017 Oct;18(10):1160-1172
pubmed: 28783152
Periodontol 2000. 2019 Feb;79(1):15-21
pubmed: 30887589
J Periodontol. 2015 May;86(5):611-22
pubmed: 25688694
J Leukoc Biol. 2014 Nov;96(5):809-20
pubmed: 25082151
Cell. 2015 Aug 27;162(5):1078-89
pubmed: 26317471
J Bone Miner Res. 2009 Aug;24(8):1347-53
pubmed: 19558314
J Clin Periodontol. 2011 Mar;38 Suppl 11:114-8
pubmed: 21323708
Trends Mol Med. 2017 Nov;23(11):1024-1036
pubmed: 28988849
Nat Rev Immunol. 2015 Jan;15(1):30-44
pubmed: 25534621
J Orthop Translat. 2017 Mar 29;9:19-27
pubmed: 29662796
J Biol Chem. 2020 May 22;295(21):7261-7273
pubmed: 32280065
FASEB J. 2012 Apr;26(4):1423-30
pubmed: 22179526
J Biol Chem. 2007 Sep 14;282(37):26746-53
pubmed: 17626014
J Periodontal Res. 2010 Feb;45(1):60-70
pubmed: 19453851
Adv Drug Deliv Rev. 2018 Apr;129:254-261
pubmed: 29524586
Immunity. 2018 Dec 18;49(6):1116-1131.e7
pubmed: 30446387
Front Immunol. 2018 Mar 23;9:585
pubmed: 29662491
Sci Transl Med. 2016 Aug 17;8(352):352ra108
pubmed: 27535619
Nat Rev Immunol. 2008 May;8(5):349-61
pubmed: 18437155
Sci Transl Med. 2018 Oct 17;10(463):
pubmed: 30333238
Orthod Craniofac Res. 2005 Nov;8(4):285-91
pubmed: 16238609
Breast Cancer Res. 2011 Apr 26;13(2):R47
pubmed: 21521526
Apoptosis. 2019 Feb;24(1-2):108-118
pubmed: 30610504
Mol Cancer Ther. 2012 Mar;11(3):538-48
pubmed: 22357635
Sci Transl Med. 2015 Jun 3;7(290):290ra92
pubmed: 26041709
J Clin Invest. 2019 Jun 4;129(9):3640-3656
pubmed: 31162141
J Periodontol. 2011 Jan;82(1):136-41
pubmed: 21043802
Cancer Res. 2004 Nov 15;64(22):8451-5
pubmed: 15548717
Periodontol 2000. 2011 Jun;56(1):188-208
pubmed: 21501244
J Biomed Mater Res A. 2013 Dec;101(12):3599-606
pubmed: 23766241
J Periodontal Res. 1999 Oct;34(7):420-4
pubmed: 10685371
Periodontol 2000. 2011 Feb;55(1):87-103
pubmed: 21134230

Auteurs

Kosuke Nagai (K)

Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Institute of Clinical Chemistry and Laboratory Medicine, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.

Hidetaka Ideguchi (H)

Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Pathophysiology - Periodontal Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Tetsuhiro Kajikawa (T)

Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Xiaofei Li (X)

Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Triantafyllos Chavakis (T)

Institute of Clinical Chemistry and Laboratory Medicine, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.

Jing Cheng (J)

Department of Bioengineering, University of California, Berkeley, Berkeley, CA, USA.
Department of Materials Science and Engineering, University of California, Berkeley, Berkeley, CA, USA.
Formulation Group in R&D, Alcon, Duluth, GA, USA.

Phillip B Messersmith (PB)

Department of Bioengineering, University of California, Berkeley, Berkeley, CA, USA.
Department of Materials Science and Engineering, University of California, Berkeley, Berkeley, CA, USA.

Ellen Heber-Katz (E)

Laboratory of Regenerative Medicine, Lankenau Institute for Medical Research, Wynnewood, PA, USA.

George Hajishengallis (G)

Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH